Total Payments
$13,982
2024 Payments
$2,670
Companies
45
Transactions
777
Medicare Patients
17,642
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$13,982 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,982 | 777 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,573 | 149 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,449 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $1,397 | 90 | $0 (2024) |
| GENZYME CORPORATION | $1,043 | 44 | $0 (2024) |
| Amgen Inc. | $930.90 | 55 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $796.77 | 35 | $0 (2024) |
| Lilly USA, LLC | $701.34 | 36 | $0 (2024) |
| PFIZER INC. | $635.77 | 45 | $0 (2023) |
| UCB, Inc. | $443.74 | 17 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $438.03 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,670 | 150 | ABBVIE INC. ($631.61) |
| 2023 | $2,776 | 154 | AbbVie Inc. ($615.03) |
| 2022 | $2,093 | 113 | ABBVIE INC. ($474.19) |
| 2021 | $1,585 | 86 | Novartis Pharmaceuticals Corporation ($339.22) |
| 2020 | $1,476 | 85 | Janssen Biotech, Inc. ($293.59) |
| 2019 | $1,226 | 70 | AbbVie, Inc. ($217.90) |
| 2018 | $1,052 | 61 | AbbVie, Inc. ($218.75) |
| 2017 | $1,103 | 58 | Valeant Pharmaceuticals North America LLC ($175.12) |
All Payment Transactions
777 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Immunology | ||||||
| 12/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: Immunology | ||||||
| 12/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Immunology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Immunology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 5,042 | 8,964 | $1.2M | $378,142 |
| 2022 | 28 | 4,627 | 8,137 | $1.1M | $352,404 |
| 2021 | 30 | 4,191 | 7,469 | $1.0M | $338,397 |
| 2020 | 29 | 3,782 | 6,548 | $888,803 | $287,967 |
Total Patients
17,642
Total Services
31,118
Medicare Billing
$1.4M
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 805 | 1,058 | $196,788 | $69,383 | 35.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 782 | 987 | $214,179 | $59,382 | 27.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 358 | 401 | $94,636 | $31,858 | 33.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 393 | 675 | $74,250 | $27,849 | 37.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 697 | 851 | $115,736 | $24,636 | 21.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 128 | 157 | $53,851 | $21,627 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 209 | $52,877 | $19,782 | 37.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 546 | 3,324 | $46,536 | $18,281 | 39.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 134 | 187 | $57,409 | $17,810 | 31.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 89 | 114 | $34,998 | $14,650 | 41.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 162 | 162 | $36,936 | $13,003 | 35.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 135 | 148 | $38,332 | $12,108 | 31.6% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 76 | 91 | $31,213 | $10,716 | 34.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 123 | 135 | $29,025 | $8,246 | 28.4% |
| 69100 | Biopsy of ear | Office | 2023 | 91 | 102 | $20,910 | $4,435 | 21.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 99 | 103 | $11,845 | $4,403 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $11,900 | $3,872 | 32.5% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $8,970 | $3,247 | 36.2% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 45 | 47 | $10,622 | $2,833 | 26.7% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 28 | $8,260 | $2,537 | 30.7% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 20 | 20 | $5,200 | $1,794 | 34.5% |
| 17270 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 13 | 13 | $4,017 | $1,473 | 36.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 14 | $3,556 | $1,336 | 37.6% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 14 | 15 | $3,705 | $1,200 | 32.4% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 21 | 23 | $4,692 | $983.29 | 21.0% |
About Dr. Christopher Carr, MD
Dr. Christopher Carr, MD is a Dermatology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972829349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Carr, MD has received a total of $13,982 in payments from pharmaceutical and medical device companies, with $2,670 received in 2024. These payments were reported across 777 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($13,982).
As a Medicare-enrolled provider, Carr has provided services to 17,642 Medicare beneficiaries, totaling 31,118 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Dallas, TX
- Active Since 04/10/2010
- Last Updated 08/04/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1972829349
Products in Payments
- DUPIXENT (Biological) $1,611
- SKYRIZI (Biological) $1,495
- TREMFYA (Drug) $1,250
- COSENTYX (Biological) $1,000
- Otezla (Drug) $856.31
- TALTZ (Drug) $701.34
- EUCRISA (Drug) $635.77
- Humira (Biological) $491.17
- RINVOQ (Biological) $367.05
- COSENTYX (Drug) $326.60
- Sotyktu (Drug) $227.81
- DORYX (Drug) $219.67
- OPZELURA (Drug) $215.97
- ILUMYA (Biological) $204.61
- Bimzelx (Biological) $171.38
- Zoryve (Drug) $164.34
- REMICADE (Biological) $157.52
- DUOBRII (Drug) $154.30
- DUPIXENT (Drug) $153.11
- HUMIRA (Biological) $150.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Dallas
Dr. Jennifer Cather, M.d, M.D
Dermatology — Payments: $1.8M
Dermatology $1.8M
Dr. Joseph Merola, M.d., M.m.sc, M.D., M.M.SC
Dermatology — Payments: $1.7M
Dermatology $1.7M
Dr. Martin Menter, Md, MD
Dermatology — Payments: $1.1M
Dermatology $1.1M
Dr. So Yeon Paek, M.d, M.D
Dermatology — Payments: $637,453
Dermatology $637,453
Dr. William Abramovits, M.d, M.D
Dermatology — Payments: $634,225
Dermatology $634,225
Dr. Ross Radusky, M.d, M.D
Dermatology — Payments: $598,043
Dermatology $598,043